Cargando…

Global Inactivation of the Pla2g6 Gene in Mice Does Not Cause Dyslipidemia under Chow or High-fat Diet Conditions

BACKGROUND: Genome-wide association studies suggest that plasma triacylglyceride (TAG) in humans was associated with variation in the PLA2G6 locus, a gene that encodes calcium-independent phospholipase A(2) (iPLA(2)β). The objective of the present study is to understand the impact of genetic inactiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li, Zhong, Shumei, Li, Ying, Ji, Guang, Sundaram, Meenakshi, Yao, Zemin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Cancer Prevention 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189460/
https://www.ncbi.nlm.nih.gov/pubmed/25337551
http://dx.doi.org/10.15430/JCP.2013.18.3.235
_version_ 1782338367602556928
author Zhang, Li
Zhong, Shumei
Li, Ying
Ji, Guang
Sundaram, Meenakshi
Yao, Zemin
author_facet Zhang, Li
Zhong, Shumei
Li, Ying
Ji, Guang
Sundaram, Meenakshi
Yao, Zemin
author_sort Zhang, Li
collection PubMed
description BACKGROUND: Genome-wide association studies suggest that plasma triacylglyceride (TAG) in humans was associated with variation in the PLA2G6 locus, a gene that encodes calcium-independent phospholipase A(2) (iPLA(2)β). The objective of the present study is to understand the impact of genetic inactivation of iPLA(2)β on hepatic TAG metabolism in C57BL/6 mice. METHODS: Male iPLA(2)β(+)(/−) mice were backcrossed with female iPLA(2)β(−/−) mice for up to 10 generations prior to experiments. Lipid and lipoprotein metabolism from plasma, hepatocytes, thigh subcutaneous adipose and thigh skeletal muscle tissues of the mice were determined under various experimental conditions. RESULTS: The iPLA(2)β(−/−) mice, either male or female as compared with iPLA(2)β(+)(/)(+) littermates, showed no change in fasted or postprandial plasma TAG or total cholesterol at young (12–15 weeks) or old (40–44 weeks) ages under chow diet or high-fat diet (HFD) conditions. However, fractionation of plasma lipoproteins showed that under HFD conditions, there was a significant increase (by 40%) in apoB-100 association with VLDL(1) fractions in iPLA(2)β(−/−) mice as compared with iPLA(2)β(+)(/)(+) littermates. There was no significant difference in triglyceride or cholesterol contents in the liver, muscle, or adipose tissue between iPLA(2)β(−/−) and iPLA(2)β(+/+) littermates. Metabolic labeling experiments with cultured primary hepatocytes isolated from iPLA(2)β(−/−) mice also showed 2-fold increase in the secretion of [(35)S]methionine-labeled apoB-100 in VLDL(1) fractions as compared with that from iPLA(2)β(+)(/)(+) hepatocytes. Likewise, secretion of [(3)H]palmitate-labeled TAG from the iPLA(2)β(−/−) hepatocytes was increased by 2-fold. CONCLUSIONS: Although iPLA(2)β may play a role in TAG-rich VLDL(1) production from cultured hepatocytes, there is no evidence that inactivation of iPLA(2)β would lead to dyslipidemia in mice in vivo.
format Online
Article
Text
id pubmed-4189460
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Korean Society of Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-41894602014-10-21 Global Inactivation of the Pla2g6 Gene in Mice Does Not Cause Dyslipidemia under Chow or High-fat Diet Conditions Zhang, Li Zhong, Shumei Li, Ying Ji, Guang Sundaram, Meenakshi Yao, Zemin J Cancer Prev Original Article BACKGROUND: Genome-wide association studies suggest that plasma triacylglyceride (TAG) in humans was associated with variation in the PLA2G6 locus, a gene that encodes calcium-independent phospholipase A(2) (iPLA(2)β). The objective of the present study is to understand the impact of genetic inactivation of iPLA(2)β on hepatic TAG metabolism in C57BL/6 mice. METHODS: Male iPLA(2)β(+)(/−) mice were backcrossed with female iPLA(2)β(−/−) mice for up to 10 generations prior to experiments. Lipid and lipoprotein metabolism from plasma, hepatocytes, thigh subcutaneous adipose and thigh skeletal muscle tissues of the mice were determined under various experimental conditions. RESULTS: The iPLA(2)β(−/−) mice, either male or female as compared with iPLA(2)β(+)(/)(+) littermates, showed no change in fasted or postprandial plasma TAG or total cholesterol at young (12–15 weeks) or old (40–44 weeks) ages under chow diet or high-fat diet (HFD) conditions. However, fractionation of plasma lipoproteins showed that under HFD conditions, there was a significant increase (by 40%) in apoB-100 association with VLDL(1) fractions in iPLA(2)β(−/−) mice as compared with iPLA(2)β(+)(/)(+) littermates. There was no significant difference in triglyceride or cholesterol contents in the liver, muscle, or adipose tissue between iPLA(2)β(−/−) and iPLA(2)β(+/+) littermates. Metabolic labeling experiments with cultured primary hepatocytes isolated from iPLA(2)β(−/−) mice also showed 2-fold increase in the secretion of [(35)S]methionine-labeled apoB-100 in VLDL(1) fractions as compared with that from iPLA(2)β(+)(/)(+) hepatocytes. Likewise, secretion of [(3)H]palmitate-labeled TAG from the iPLA(2)β(−/−) hepatocytes was increased by 2-fold. CONCLUSIONS: Although iPLA(2)β may play a role in TAG-rich VLDL(1) production from cultured hepatocytes, there is no evidence that inactivation of iPLA(2)β would lead to dyslipidemia in mice in vivo. Korean Society of Cancer Prevention 2013-09 /pmc/articles/PMC4189460/ /pubmed/25337551 http://dx.doi.org/10.15430/JCP.2013.18.3.235 Text en Copyright © 2013 Korean Society of Cancer Prevention This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Zhang, Li
Zhong, Shumei
Li, Ying
Ji, Guang
Sundaram, Meenakshi
Yao, Zemin
Global Inactivation of the Pla2g6 Gene in Mice Does Not Cause Dyslipidemia under Chow or High-fat Diet Conditions
title Global Inactivation of the Pla2g6 Gene in Mice Does Not Cause Dyslipidemia under Chow or High-fat Diet Conditions
title_full Global Inactivation of the Pla2g6 Gene in Mice Does Not Cause Dyslipidemia under Chow or High-fat Diet Conditions
title_fullStr Global Inactivation of the Pla2g6 Gene in Mice Does Not Cause Dyslipidemia under Chow or High-fat Diet Conditions
title_full_unstemmed Global Inactivation of the Pla2g6 Gene in Mice Does Not Cause Dyslipidemia under Chow or High-fat Diet Conditions
title_short Global Inactivation of the Pla2g6 Gene in Mice Does Not Cause Dyslipidemia under Chow or High-fat Diet Conditions
title_sort global inactivation of the pla2g6 gene in mice does not cause dyslipidemia under chow or high-fat diet conditions
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189460/
https://www.ncbi.nlm.nih.gov/pubmed/25337551
http://dx.doi.org/10.15430/JCP.2013.18.3.235
work_keys_str_mv AT zhangli globalinactivationofthepla2g6geneinmicedoesnotcausedyslipidemiaunderchoworhighfatdietconditions
AT zhongshumei globalinactivationofthepla2g6geneinmicedoesnotcausedyslipidemiaunderchoworhighfatdietconditions
AT liying globalinactivationofthepla2g6geneinmicedoesnotcausedyslipidemiaunderchoworhighfatdietconditions
AT jiguang globalinactivationofthepla2g6geneinmicedoesnotcausedyslipidemiaunderchoworhighfatdietconditions
AT sundarammeenakshi globalinactivationofthepla2g6geneinmicedoesnotcausedyslipidemiaunderchoworhighfatdietconditions
AT yaozemin globalinactivationofthepla2g6geneinmicedoesnotcausedyslipidemiaunderchoworhighfatdietconditions